NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Breaking my resolution again.

Have you ever considered that LP’s role has been to stall investors until a positive critical milestone is achieved? Let’s pretend that milestone is MAA, and then her “work” is complete. We really don’t see NWBO filings looking at any work or incentives beyond that.

LP is going to be a billionaire on any modest sellout. They only need to get the PPS to half or maybe even one third of that prior to any BO premium.

LP is fond of playing this dichotomy in front of investors. “It’s out of our hands” and in the hands of contractors, but then immediately talks as if she is doing the contracting work.

Nice has admitted they are expecting something from NWBO in early 2023. I’m pretty certain it’s an evidence submission. I’m pretty confident no evidence submission to NICE occurs until Sawston commercially licensed and MAA is submitted. Essentially all at around the same time. I’m pretty certain the original arm data that Ex keeps referencing, and Senti recently referenced will be even more mature and positive at that time.

“Just my lousy opinion,” as an old poster here used to say.

So instead of hearing more about that, we hear careful LP complaining about scanning documents. The horror, the horror.